Table of contents
Volume 82, Issue 1
Published online 10 December 1999 (1-250)
Editorials |
Regular Articles |
Short Communications |
Short Communication |
Letters to the Editor |
Book Review
Regular Article
Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group FREE
Br J Cancer 82: 1-3; doi:10.1054/bjoc.1999.0866
Editorials
Economics of stem cell transplantation for lymphoma: counting the cost of living FREE
J W Sweetenham
Br J Cancer 82: 4-6; doi:10.1054/bjoc.1999.0867
Optimizing cancer care: specialization, coordination and cooperation FREE
A G Renehan and S T O'Dwyer
Br J Cancer 82: 7-8; doi:10.1054/bjoc.1999.0868
Regular Articles
Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis FREE
N Umetani, S Sasaki, T Masaki, T Watanabe, K Matsuda and T Muto
Br J Cancer 82: 9-15; doi:10.1054/bjoc.1999.0869
Preferential down-regulation of phospholipase C-
in Ewing's sarcoma cells transfected with antisense EWS-Fli-1 FREE
T Dohjima, T Ohno, Y Banno, Y Nozawa, Y Wen-yi and K Shimizu
Br J Cancer 82: 16-19; doi:10.1054/bjoc.1998.0870
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma FREE
N Durany, J Joseph, O M Jimenez, F Climent, P L Fernández, F Rivera and J Carreras
Br J Cancer 82: 20-27; doi:10.1054/bjoc.1999.0871
Inhibition of I
B-
phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells FREE
J Miyakoshi and K Yagi
Br J Cancer 82: 28-33; doi:10.1054/bjoc.1999.0872
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells FREE
S Isonishi, K Ohkawa, T Tanaka and S B Howell
Br J Cancer 82: 34-38; doi:10.1054/bjoc.1999.0873
Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells FREE
M V Cronauer, C Nessler-Menardi, H Klocker, K Maly, A Hobisch, G Bartsch and Z Culig
Br J Cancer 82: 39-45; doi:10.1054/bjoc.1999.0874
Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2 FREE
H Kunisue, J Kurebayashi, T Otsuki, C K Tang, M Kurosumi, S Yamamoto, K Tanaka, H Doihara, N Shimizu and H Sonoo
Br J Cancer 82: 46-51; doi:10.1054/bjoc.1999.0875
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells FREE
H K Rooprai, G J Rucklidge, C Panou and G J Pilkington
Br J Cancer 82: 52-55; doi:10.1054/bjoc.1999.0876
Targeted photodestruction of human colon cancer cells using charged 17.1A chlorine6 immunoconjugates FREE
M Del Governatore, M R Hamblin, E E Piccinini, G Ugolini and T Hasan
Br J Cancer 82: 56-64; doi:10.1054/bjoc.1999.0877
Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung FREE
S Petersen, M Aninat-Meyer, K Schlüns, K Gellert, M Dietel and I Petersen
Br J Cancer 82: 65-73; doi:10.1054/bjoc.1999.0878
Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model FREE
R J Mairs, C L Wideman, W J Angerson, T L Whateley, M S Reza, J R Reeves, L M Robertson, A Neshasteh-Riz, R Rampling, J Owens, D Allan and D I Graham
Br J Cancer 82: 74-80; doi:10.1054/bjoc.1999.0879
Short Communications
The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma FREE
S M Beard, P C Lorigan and F C Sampson
Br J Cancer 82: 81-84; doi:10.1054/bjoc.1999.0880
Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy FREE
K Trieb, R Gerth, G Holzer, J G Grohs, P Berger and R Kotz
Br J Cancer 82: 85-87; doi:10.1054/bjoc.1999.0881
Regular Articles
Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging FREE
Y Kinoshita, K Kohshi, N Kunugita, T Tosaki and A Yokota
Br J Cancer 82: 88-92; doi:10.1054/bjoc.1999.0882
Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy FREE
P J Barrett-Lee, N P Bailey, M E R O'Brien and E Wager
Br J Cancer 82: 93-97; doi:10.1054/bjoc.1999.0883
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin FREE
G V Kornek, A Schratter-Sehn, A Marczell, D Depisch, J Karner, G Krauss, K Haider, W Kwasny, G Locker and W Scheithauer
Br J Cancer 82: 98-103; doi:10.1054/bjoc.1999.0884
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group FREE
Y Segawa, H Ueoka, K Kiura, H Kamei, M Tabata, K Sakae, Y Hiraki, S Kawahara, K Eguchi, S Hiraki and M Harada for the Okayama Lung Cancer Study Group
Br J Cancer 82: 104-111; doi:10.1054/bjoc.1999.0885
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues FREE
R H N van Schaik, C D J Wierikx, M A Timmerman, M H Oomen, W M van Weerden, T H van der Kwast, G J van Steenbrugge and F H de Jong
Br J Cancer 82: 112-117; doi:10.1054/bjoc.1999.0886
Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors FREE
T M Proebstle, W Jiang, J Högel, U Keilholz, L Weber and C Voit
Br J Cancer 82: 118-123; doi:10.1054/bjoc.1998.0887
Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa FREE
H S Chave, A C Gough, K Palmer, S R Preston and J N Primrose
Br J Cancer 82: 124-130; doi:10.1054/bjoc.1998.0888
Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma FREE
L M Butler, A Dobrovic, T Bianco and P A Cowled
Br J Cancer 82: 131-135; doi:10.1054/bjoc.1999.0889
p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer FREE
H A Phillips, G C W Howard and W R Miller
Br J Cancer 82: 136-141; doi:10.1054/bjoc.1999.0890
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours FREE
P A Curmi, C Noguès, S Lachkar, N Carelle, M-P Gonthier, A Sobel, R Lidereau and I Bièche
Br J Cancer 82: 142-150; doi:10.1054/bjoc.1999.0891
Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families FREE
T Peelen, M van Vliet, A Bosch, G Bignell, H F A Vasen, J G M Klijn, H Meijers-Heijboer, M Stratton, G-J B van Ommen, C J Cornelisse and P Devilee
Br J Cancer 82: 151-156; doi:10.1054/bjoc.1999.0892
Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction FREE
T Weber, J Lacroix, J Weitz, K Amnan, A Magener, T Hölting, E Klar, C Herfarth and M von Knebel Doeberitz
Br J Cancer 82: 157-160; doi:10.1054/bjoc.1999.0893
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression FREE
J P Crew, S Fuggle, R Bicknell, D W Cranston, A de Benedetti and A L Harris
Br J Cancer 82: 161-166; doi:10.1054/bjoc.1999.0894
Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? FREE
P F Bowrey, J King, C Magarey, P Schwartz, P Marr, E Bolton and D L Morris
Br J Cancer 82: 167-170; doi:10.1054/bjoc.1999.0895
Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients FREE
J M Ferrero, M C Etienne, J L Formento, M Francoual, P Rostagno, I Peyrottes, F Ettore, E Teissier, P Leblanc-Talent, M Namer and G Milano
Br J Cancer 82: 171-177; doi:10.1054/bjoc.1999.0896
Bcl-w expression in colorectal adenocarcinoma FREE
J W Wilson, M C Nostro, M Balzi, P Faraoni, F Cianchi, A Becciolini and C S Potten
Br J Cancer 82: 178-185; doi:10.1054/bjoc.1999.0897
Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer FREE
E O Olapade-Olaopa, D K Moscatello, E H MacKay, T Horsburgh, D P S Sandhu, T R Terry, A J Wong and F K Habib
Br J Cancer 82: 186-194; doi:10.1054/bjoc.1999.0898
Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells FREE
M Barshishat, S Polak-Charcon and B Schwartz
Br J Cancer 82: 195-203; doi:10.1054/bjoc.1999.0899
Short Communication
Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland FREE
C Bosetti, E Negri, S Franceschi, E Conti, F Levi, F Tomei and C La Vecchia
Br J Cancer 82: 204-207; doi:10.1054/bjoc.1999.0900
Regular Articles
Multiple cancer site comparison of adjusted survival by hospital of treatment: an East Anglian study FREE
D Stockton and T Davies
Br J Cancer 82: 208-212; doi:10.1054/bjoc.1999.0901
Sample size calculation for clinical trials: the impact of clinician beliefs FREE
P M Fayers, A Cuschieri, J Fielding, J Craven, B Uscinska and L S Freedman
Br J Cancer 82: 213-219; doi:10.1054/bjoc.1999.0902
Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life FREE
A Mattsson, W Leitz and L E Rutqvist
Br J Cancer 82: 220-226; doi:10.1054/bjoc.1999.0903
Gender differences in lung cancer risk by smoking: a multicentre case–control study in Germany and Italy FREE
M Kreuzer, P Boffetta, E Whitley, W Ahrens, V Gaborieau, J Heinrich, K H Jöckel, L Kreienbrock, S Mallone, F Merletti, F Roesch, P Zambon and L Simonato
Br J Cancer 82: 227-233; doi:10.1054/bjoc.1999.0904
Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia FREE
J P Neglia, M S Linet, X O Shu, R K Severson, J D Potter, A C Mertens, W Wen, J H Kersey and L L Robison
Br J Cancer 82: 234-240; doi:10.1054/bjoc.1999.0905
Height-related risk factors for prostate cancer FREE
A E Norrish, C U McRae, I M Holdaway and R T Jackson
Br J Cancer 82: 241-245; doi:10.1054/bjoc.1999.0906
Letters to the Editor
Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, -interferon (leucocyte) and tamoxifen FREE
Br J Cancer 82: 246; doi:10.1054/bjoc.1999.0907
Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, -interferon (leucocytic) and tamoxifen – reply FREE
Br J Cancer 82: 246-247; doi:10.1054/bjoc.1999.0952
Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins FREE
Br J Cancer 82: 247-248; doi:10.1054/bjoc.1999.0908
Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins—reply FREE
Br J Cancer 82: 248-249; doi:10.1054/bjoc.1999.0953
The relation of gelatinase (MMP-2 and -9) expression with distant site metastasis and tumour aggressiveness in colorectal cancer FREE
Br J Cancer 82: 249; doi:10.1054/bjoc.1999.0909
Book Review
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
